Approval · Notice of Compliance 473 · 2003
ATTENADE: Notice of Compliance 473
Issued August 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 473
- Date
- August 11, 2003
- Company
- Biovail Pharmaceuticals Canada Division Of Biovail CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Central nervous system stimulant
Products in this notice
Medicinal ingredients
- DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 MG per TAB
- DEXMETHYLPHENIDATE HYDROCHLORIDE 5 MG per TAB
- DEXMETHYLPHENIDATE HYDROCHLORIDE 10 MG per TAB